No Disinfection*

Mitigate your risk of M. Chimaera.

Remove residual water from your cardioplegia circuit with Quest’s No Disinfection Technology.

The Quest MPS^®3 ND System, a revolutionary development from Quest Medical, Inc., mitigates risk and cost associated with Surgical Site Infections (SSI) due to Mycobacterium Chimaera (M. chimaera).

Benefits of ND Technology

State of the art technology with dripless connectors:

• Remove water from the MPS System used to thermoregulate your patient’s cardioplegia circuit.

• Mitigate risk of M. Chimaera contaminating the Cardiac O.R. sterile field

ND Technology Cost Savings

Average Annual Disinfection Cost- $7,000 per unit⁵

$28,219
avg SSI cost/incident⁷

M. Chimaera

M. Chimaera- A slow growing bacterium, part of a group called non-tuberculous Mycobacterium bacteria (NTM) commonly found in water.

Annually, more than 250,000 heart bypass procedures are performed utilizing devices associated with these infections.⁶

Want to Know More, or Schedule a Demo?

Let’s Talk.

* The Quest MPS3 ND System elimiinates the need for disinfecting the internal water circuit. With the Quest MPS3 ND System, only exterior surfaces of the device need disinfection. Refer to the Quest MPS3 ND operations manual for exterior surface disinfection instructions.

5 Disinfecting Costs; Data on file

6 Estimating the Additional Hospital Inpatient Cost and Mortality Associated With Selected Hospital-Acquired Conditions. Content last reviewed November 2017. Agency for Healthcare Research and Quality, Rockville, MD.